Equities

MedMira Inc

MedMira Inc

Actions
Health CareMedical Equipment and Services
  • Price (CAD)0.09
  • Today's Change0.00 / 0.00%
  • Shares traded96.00k
  • 1 Year change0.00%
  • Beta--
Data delayed at least 15 minutes, as of May 16 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

MedMira Inc. is a Canada-based biotechnology company. The Company, through its subsidiaries, is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. The Company invests in research in order to maintain and expand its position in the global diagnostics market. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. The Company is the developer and owner of Rapid Vertical Flow (RVF) Technology. The Company's rapid test applications built on RVF Technology provide hospitals, labs, clinics and individuals with instant diagnosis for diseases such as Human Immunodeficiency Virus (HIV), Syphilis and hepatitis C in just three easy steps. The Company's tests are sold under the Reveal, Multiplo and Miriad brands in global markets. The Company's manufacturing facilities are located in Halifax, Nova Scotia, Canada.

  • Revenue in CAD (TTM)407.78k
  • Net income in CAD-2.92m
  • Incorporated1999
  • Employees65.00
  • Location
    MedMira Inc155 Chain Lake Dr.,, Suite 1HALIFAX B3S 1B3CanadaCAN
  • Phone+1 (902) 450-1588
  • Fax+1 (902) 450-1580
  • Websitehttps://medmira.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Decibel Cannabis Company Inc115.96m-1.77m47.10m----1.0235.150.4062-0.0045-0.00450.27390.11290.8171.517.66---1.25-3.55-2.04-5.1936.1038.83-1.53-7.130.36851.210.5122--46.18--60.33---32.45--
Microbix Biosystems Inc22.42m3.72m48.16m69.0012.931.769.392.150.02710.02710.16290.19940.64611.626.75--10.71-0.972911.77-1.1755.8352.3016.57-1.556.322.600.197---13.435.71-102.21---3.56--
Helix Biopharma Corp.0.00-5.94m48.24m9.00--73.15-----0.0284-0.02840.000.00290.00----0.00-177.39-261.49----------------0.00------4.16---28.36--
MustGrow Biologics Corp4.71m-676.95k52.21m0.00--9.68--11.08-0.0144-0.01440.09440.10850.6697--51.61---9.62-50.41-11.96-59.28-----14.37-298.73----0.1197--72,619.13372.5487.84------
LSL Pharma Group Inc10.03m-8.47m53.10m----4.67--5.30-0.1117-0.11170.12640.105----------------16.40---84.48--0.2053-1.140.6527--------------
Satellos Bioscience Inc0.00-21.13m54.21m12.00--1.57-----0.1718-0.17180.000.30590.00----0.00-93.29-107.22-109.86-136.58------------0.00-------40.33--459.46--
Medmira Inc407.78k-2.92m63.53m65.00------155.81-0.0042-0.00420.0006-0.02290.09960.78990.3142---71.41-69.95----61.5466.76-717.02-187.610.1342-2.09-----54.57-5.98-46.08------
KDA Group Inc186.28k133.66k68.49m--194.034.4078.39367.680.0020.09260.00120.08860.0079--0.0693---0.4146-17.96-0.8534-44.6936.5126.76-52.24-28.00---4.310.1287---22.20-62.03106.88--31.67--
Auxly Cannabis Group Inc102.35m-60.27m68.91m369.00--0.6613--0.6733-0.0596-0.05960.10170.08320.34542.265.92277,374.00-20.34-21.47-30.18-24.997.935.08-58.89-124.150.3836-1.400.4399--6.99166.8565.84---40.92--
Cannara Biotech Inc73.38m6.22m72.11m--11.520.90776.060.98260.06950.06950.81730.88140.53372.087.46--4.52-4.466.23-4.9510.0617.868.48-15.880.3582-2.460.384--59.91--201.26------
ZYUS Life Sciences Corp351.00k-42.59m76.61m2.00--3.31--218.26-0.639-0.6390.00580.32630.00660.05770.8069---80.10-57.88-108.06-71.1948.72-16.16-12,134.19-10,367.370.5547-4.560.2979--17.79213.99-72.73------
Data as of May 16 2024. Currency figures normalised to MedMira Inc's reporting currency: Canadian Dollar CAD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.